← Back to Analyst Consensus 
ATNM Buy
Actinium Pharmaceuticals, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 31, 2026 | Stephens & Co. | reiterate | Overweight → Overweight | — | 54% |
| Jun 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| May 12, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Apr 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Apr 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Mar 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Nov 19, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $5 | 54% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Aug 6, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Aug 6, 2024 | Maxim Group | maintain | Buy → Buy | $5 | 42% |
| Jul 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Jun 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| May 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| May 14, 2024 | Stephens & Co. | initiate | — → Overweight | $25 | 54% |
| May 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Apr 30, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $21 | 50% |
| Apr 29, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Apr 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Apr 1, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $21 | 50% |
| Mar 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Mar 19, 2024 | Maxim Group | maintain | Buy → Buy | $30 | 42% |
| Mar 19, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Mar 11, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Dec 11, 2023 | B. Riley Securities | maintain | Buy → Buy | $16 | 54% |
| Oct 3, 2023 | B. Riley Securities | reiterate | Buy → Buy | $20 | 54% |
| Sep 7, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $50 | 44% |
| Sep 6, 2023 | HSBC | initiate | — → Buy | $11.6 | 53% |
| Aug 15, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| May 16, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $53 | 44% |
| Apr 20, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $53 | 44% |
Price Target Trend
Apr 24, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days